TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Certified by Founder
Lodge
Schusterman Family Investments (SFI)
investor
United States
- New York, NY
- 16/11/2022
- Series A
- $26,000,000
Schusterman Family Investments (SFI) operates as the investment office of the Schusterman Family and its philanthropic entities, investing across multiple asset classes in both the private and public markets.
- Industry Investment Management
- Website https://www.schusterman.org/who-we-are/our-approach
- LinkedIn https://www.linkedin.com/company/schusterman-family-investments/about/
IC Realtime | $2,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)